NORTH READING, Mass.--(BUSINESS WIRE)--Teradyne, Inc. (NYSE: TER) reported revenue of $411 million for the second quarter of 2011 of which $343 million was in Semiconductor Test and $68 million in Systems Test Group. On a non-GAAP basis, Teradyne’s income from continuing operations in the second quarter was $101.5 million, or $0.50 per diluted share, which excluded acquired intangible asset amortization, non-cash convertible debt interest and restructuring and other charges. GAAP income from continuing operations for the second quarter was $89.9 million, or $0.39 per diluted share.
Bookings in the second quarter of 2011 were $333 million of which $257 million were in Semiconductor Test and $76 million in the Systems Test Group.
"We delivered solid financial results in the second quarter marking the sixth quarter in a row of above model profitability," said Mike Bradley, Teradyne President and CEO. “We saw continued strength in Hard Disk Drive Test orders as we expand both the performance and customer base of our Neptune product line. While System on a Chip (SOC) test orders slowed substantially in the quarter, the wireless and media processor, power management, and imaging segments were the strongest, driven by both design wins and capacity expansions.”
"With the softening order rate in semiconductor test dictating lower shipments in the third quarter, we're pleased to see increasing HDD test shipments offset some of that decline. While delivering lower gross margins than our other businesses, HDD test is on track to deliver model profitability on record revenues this year.”
Guidance for the third quarter of 2011 is for revenue of $320 million to $340 million, with non-GAAP income from continuing operations per diluted share of $0.22 to $0.26 and GAAP income from continuing operations per diluted share of $0.15 to $0.18. Non-GAAP guidance excludes acquired intangible asset amortization, non-cash convertible debt interest and restructuring and other charges.
Webcast
A conference call to discuss the second quarter 2011 results, along with management's business outlook is scheduled at 10 a.m. EDT, Thursday, July 28. The call will be broadcast simultaneously over the Internet. Interested investors should access the webcast at www.teradyne.com and click on "Investors" at least five minutes before the call begins.
A replay will be available approximately two hours after the completion of the call. The replay number in the U.S. & Canada is 800-642-1687. The replay number outside the U.S. & Canada is 706-645-9291. The pass code for both numbers is 82250574. A replay will also be available on the Teradyne website at www.teradyne.com and by phone. The phone replay will be available through August 13, 2011.
Non-GAAP Results
In addition to disclosing results that are determined in accordance with GAAP, Teradyne also discloses non-GAAP results of operations that exclude certain income items and charges. These results are provided as a complement to results provided in accordance with GAAP. Non-GAAP income from operations and non-GAAP income from continuing operations exclude acquired intangible asset amortization, non-cash convertible debt interest, and restructuring and other, net. GAAP requires that these items be included in determining income from operations and income from continuing operations. Non-GAAP income from operations, non-GAAP income from continuing operations, non-GAAP income from operations and non-GAAP income from continuing operations as a percentage of revenue, and non-GAAP income from continuing operations per share are non-GAAP measures presented to provide meaningful supplemental information regarding Teradyne's baseline performance before gains, losses or other charges that may not be indicative of Teradyne’s current core business or future outlook. These non-GAAP measures are used to make operational decisions, to determine employee compensation, to forecast future operational results, and for comparison with Teradyne’s business plan, historical operating results and the operating results of Teradyne’s competitors. Non-GAAP diluted shares include the impact of Teradyne’s call option on its shares. Management believes each of these non-GAAP measures provides useful supplemental information for investors, allowing greater transparency to the information used by management in its operational decision making and in the review of Teradyne’s financial and operational performance, as well as facilitating meaningful comparisons of Teradyne’s results in the current period compared with those in prior and future periods. A reconciliation of each available GAAP to non-GAAP financial measure discussed in this press release is contained in the attached exhibits and on the Teradyne website at www.teradyne.com by clicking on "Investors" and then selecting the "GAAP to Non-GAAP Reconciliation" link. The presentation of non-GAAP measures is not meant to be considered in isolation, as a substitute for, or superior to, financial measures or information provided in accordance with GAAP.
About Teradyne
Teradyne (NYSE:TER) is the leading supplier of Automatic Test Equipment used to test complex electronics used in the consumer electronics, automotive, computing, telecommunications, and aerospace and defense industries. Teradyne had 2010 sales of $1.6 billion and employs about 2,900 people worldwide. For more information, visit www.teradyne.com. Teradyne(R) is a registered trademark of Teradyne, Inc. in the U.S. and other countries.
Safe Harbor Statement
This release contains forward-looking statements regarding future business prospects, Teradyne’s results of operations and market conditions. Such statements are based on the current assumptions and expectations of Teradyne’s management and are neither promises nor guarantees of future performance. You can identify these forward-looking statements based on the context of the statements and by the fact that they use words such as “will,” “anticipate,” “expect,” “project,” “intend,” “plan,” “believe,” “target” and other words and terms of similar meaning in connection with any discussion of future operating or financial performance. There can be no assurance that management’s estimates of Teradyne’s future results or other forward looking statements will be achieved. Important factors that could cause actual results to differ materially from those presently expected include: conditions affecting the markets in which Teradyne operates; decreased or delayed product demand; increased competition in certain markets resulting from the merger of Advantest and Verigy; and other events, factors and risks disclosed in filings with the SEC, including, but not limited to, the “Risk Factors” section of Teradyne’s Annual Report on Form 10-K for the fiscal year ended December 31, 2010 and Quarterly Report on Form 10-Q for the period ended April 3, 2011. The forward-looking statements provided by Teradyne in this press release represent management’s views as of the date of this release. Teradyne anticipates that subsequent events and developments may cause management's views to change. However, while Teradyne may elect to update these forward-looking statements at some point in the future, Teradyne specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Teradyne's views as of any date subsequent to the date of this release.
TERADYNE, INC. REPORT FOR SECOND FISCAL QUARTER OF 2011 | ||||||||||||||||||||
CONDENSED CONSOLIDATED OPERATING STATEMENTS | ||||||||||||||||||||
(In thousands, except per share amounts) | ||||||||||||||||||||
Quarter Ended | Six Months Ended | |||||||||||||||||||
July 3, 2011 |
April 3, 2011 | July 4, 2010 | July 3, 2011 | July 4, 2010 | ||||||||||||||||
Net Revenues | $ | 410,519 | $ | 377,161 | $ | 445,271 | $ | 787,680 | $ | 764,609 | ||||||||||
Cost of Revenues (1) | 195,433 | 184,752 | 194,369 | 380,185 | 343,831 | |||||||||||||||
Gross Profit | 215,086 | 192,409 | 250,902 | 407,495 | 420,778 | |||||||||||||||
Operating Expenses: | ||||||||||||||||||||
Engineering and Development | 47,393 | 47,977 | 49,341 | 95,370 | 97,278 | |||||||||||||||
Selling and Administrative | 57,481 | 58,229 | 57,730 | 115,710 | 112,417 | |||||||||||||||
Acquired Intangible Asset Amortization | 7,291 | 7,291 | 7,313 | 14,582 | 14,668 | |||||||||||||||
Restructuring and Other, net (2) | 1,279 | 413 | 371 | 1,692 | 1,274 | |||||||||||||||
Operating Expenses | 113,444 | 113,910 | 114,755 | 227,354 | 225,637 | |||||||||||||||
Income from Operations | 101,642 | 78,499 | 136,147 | 180,141 | 195,141 | |||||||||||||||
Interest & Other (3) | (3,913 | ) | (4,889 | ) | (4,074 | ) | (8,802 | ) | (9,139 | ) | ||||||||||
Income from Continuing Operations Before Income Taxes | 97,729 | 73,610 | 132,073 | 171,339 | 186,002 | |||||||||||||||
Income Tax Provision | 7,839 | 5,486 | 9,543 | 13,325 | 14,373 | |||||||||||||||
Income from Continuing Operations | 89,890 | 68,124 | 122,530 | 158,014 | 171,629 | |||||||||||||||
Income (Loss) from Discontinued Operations Before Income Taxes (4) | - | 1,278 | (381 | ) | 1,278 | 620 | ||||||||||||||
Income Tax Benefit | - | (267 | ) | - | (267 | ) | - | |||||||||||||
Income (Loss) from Discontinued Operations | - | 1,545 | (381 | ) | 1,545 | 620 | ||||||||||||||
(Loss) Gain on Disposal of Discontinued Operations (net of income
tax provision |
(832 | ) | 25,203 | - | 24,371 | - | ||||||||||||||
Net Income | $ | 89,058 | $ | 94,872 | $ | 122,149 | $ | 183,930 | $ | 172,249 | ||||||||||
Income per Common Share from Continuing Operations: |
||||||||||||||||||||
Basic | $ | 0.48 | $ | 0.37 | $ | 0.68 | $ | 0.85 | $ | 0.97 | ||||||||||
Diluted | $ | 0.39 | $ | 0.29 | $ | 0.55 | $ | 0.68 | $ | 0.79 | ||||||||||
Net Income per Common Share: |
||||||||||||||||||||
Basic | $ | 0.48 | $ | 0.51 | $ | 0.68 | $ | 0.99 | $ | 0.97 | ||||||||||
Diluted | $ | 0.39 | $ | 0.41 | $ | 0.55 | $ | 0.80 | $ | 0.79 | ||||||||||
Weighted Average Common Shares - Basic | 185,367 | 184,720 | 179,990 | 185,044 | 178,429 | |||||||||||||||
Weighted Average Common Shares - Diluted (5) | 230,452 | 232,080 | 231,541 | 231,266 | 228,909 | |||||||||||||||
Net Orders | $ | 333,170 | $ | 435,077 | $ | 505,755 | $ | 768,247 | $ | 1,028,567 | ||||||||||
(1) Cost of Revenues includes: | Quarter Ended | Six Months Ended | ||||||||||||||||||
July 3, 2011 | April 3, 2011 | July 4, 2010 | July 3, 2011 | July 4, 2010 | ||||||||||||||||
Sale of Previously Written Down Inventory | $ | (764 | ) | $ | (3,022 | ) | $ | (5,232 | ) | $ | (3,786 | ) | $ | (5,232 | ) | |||||
Provision for Excess and Obsolete Inventory | 1,716 | 4,627 | 276 | 6,343 | 1,454 | |||||||||||||||
$ | 952 | $ | 1,605 | $ | (4,956 | ) | $ | 2,557 | $ | (3,778 | ) | |||||||||
(2) Restructuring and Other, net consists of: | Quarter Ended | Six Months Ended | ||||||||||||||||||
July 3, 2011 | April 3, 2011 | July 4, 2010 | July 3, 2011 | July 4, 2010 | ||||||||||||||||
Employee Severance | $ | 344 | $ | 844 | $ | 371 | $ | 1,188 | $ | 1,274 | ||||||||||
Non-U.S. Pension Settlement | 935 | - | - | 935 | - | |||||||||||||||
Facility Related | - | (431 | ) | - | (431 | ) | - | |||||||||||||
$ | 1,279 | $ | 413 |
$ |
371 | $ | 1,692 | $ | 1,274 | |||||||||||
(3) Interest & Other includes: | Quarter Ended | Six Months Ended | ||||||||||||||||||
July 3, 2011 | April 3, 2011 | July 4, 2010 | July 3, 2011 | July 4, 2010 | ||||||||||||||||
Non-Cash Convertible Debt Interest | $ | 2,957 | $ | 2,858 |
$ |
2,580 | $ | 5,815 | $ | 5,074 | ||||||||||
(4) On March 21, 2011, Teradyne completed the sale of its
Diagnostic Solutions business unit to SPX Corporation for a gain
of $24.4 million. |
||||||||||||||||||||
(5) Under GAAP, when calculating diluted earnings per share, convertible debt must be assumed to have converted if the effect on EPS would be dilutive. Diluted shares assume the conversion of the convertible debt as the effect would be dilutive. Accordingly, for the quarters ended July 3, 2011, April 3, 2011, and July 4, 2010, 22.7 million, 23.4 million and 34.7 million shares, respectively, have been included in diluted shares and net interest expense of $0, $0 and $4.4 million, respectively, has been added back to income from continuing operations and net income for the diluted earnings per share calculations. For the six months ended July 3, 2011 and July 4, 2010, 23.0 million and 34.7 million shares, respectively, have been included in diluted shares and net interest expense of $0 and $8.8 million, respectively, has been added back to income from continuing operations and net income for the diluted earnings per share calculations. | ||||||||||||||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) | ||||||||
July 3, 2011 | December 31, 2010 | |||||||
Assets | ||||||||
Cash and Cash Equivalents | $ | 455,398 | $ | 397,737 | ||||
Marketable Securities | 453,942 | 409,061 | ||||||
Accounts Receivable | 207,823 | 168,756 | ||||||
Inventories | 141,518 | 116,841 | ||||||
Deferred Tax Assets | 22,801 | 22,730 | ||||||
Prepayments and Other Current Assets | 61,946 | 52,780 | ||||||
Current Assets from Discontinued Operations (1) | - | 8,713 | ||||||
Total Current Assets | 1,343,428 | 1,176,618 | ||||||
Net Property, Plant and Equipment | 233,432 | 231,108 | ||||||
Long-Term Marketable Securities | 281,978 | 248,696 | ||||||
Retirement Plan Assets | 14,456 | 13,981 | ||||||
Intangible Assets | 108,357 | 122,941 | ||||||
Other Assets | 16,644 | 16,542 | ||||||
Long-Term Assets from Discontinued Operations (1) | - | 469 | ||||||
Total Assets | $ | 1,998,295 | $ | 1,810,355 | ||||
Liabilities | ||||||||
Accounts Payable | $ | 106,993 | $ | 81,142 | ||||
Accrued Employees' Compensation and Withholdings | 75,018 | 105,374 | ||||||
Deferred Revenue and Customer Advances | 98,723 | 105,568 | ||||||
Other Accrued Liabilities | 59,889 | 57,145 | ||||||
Accrued Income Taxes | 9,888 | 8,465 | ||||||
Current Debt | 2,475 | 2,450 | ||||||
Current Liabilities from Discontinued Operations (1) | - | 3,560 | ||||||
Total Current Liabilities | 352,986 | 363,704 | ||||||
Long-Term Deferred Revenue and Customer Advances | 50,064 | 71,558 | ||||||
Retirement Plan Liabilities | 77,154 | 72,071 | ||||||
Deferred Tax Liabilities | 9,973 | 9,849 | ||||||
Other Long-Term Liabilities | 19,359 | 19,448 | ||||||
Long-Term Debt | 154,821 | 150,182 | ||||||
Long-Term Liabilities from Discontinued Operations (1) | - | 1,355 | ||||||
Total Liabilities | 664,357 | 688,167 | ||||||
Shareholders' Equity | 1,333,938 | 1,122,188 | ||||||
Total Liabilities and Shareholders' Equity | $ | 1,998,295 | $ | 1,810,355 | ||||
(1) On March 21, 2011, Teradyne completed the sale of its Diagnostic Solutions business unit to SPX Corporation. The assets and liabilities of the discontinued business unit have been included within discontinued operations at December 31, 2010. | ||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) | ||||||||||||||||||
Quarter Ended | Six Months Ended | |||||||||||||||||
July 3, 2011 | July 4, 2010 | July 3, 2011 | July 4, 2010 | |||||||||||||||
Cash flows from operating activities: | ||||||||||||||||||
Net income | $ | 89,058 | $ | 122,149 | $ | 183,930 | $ | 172,249 | ||||||||||
Less: (Loss) income from discontinued operations | - | (381 | ) | 1,545 | 620 | |||||||||||||
Less: (Loss) gain on disposal of discontinued operations | (832 | ) | - | 24,371 | - | |||||||||||||
Income from continuing operations | 89,890 | 122,530 | 158,014 | 171,629 | ||||||||||||||
Adjustments to reconcile income from continuing operations to net |
||||||||||||||||||
Depreciation | 12,588 | 13,244 | 25,645 | 26,403 | ||||||||||||||
Amortization | 12,849 | 11,173 | 25,291 | 23,105 | ||||||||||||||
Stock-based compensation | 7,218 | 7,168 | 14,682 | 15,141 | ||||||||||||||
Provision for excess and obsolete inventory | 1,716 | 276 | 6,343 | 1,454 | ||||||||||||||
Tax benefit related to stock options and restricted stock units | (3,717 | ) | - | (3,717 | ) | - | ||||||||||||
Other | 804 | 475 | 1,424 | 1,659 | ||||||||||||||
Changes in operating assets and liabilities, net of businesses sold: | ||||||||||||||||||
Accounts receivable | (21,569 | ) | (70,041 | ) | (39,067 | ) | (123,184 | ) | ||||||||||
Inventories | (4,297 | ) | 9,337 | (15,006 | ) | 24,231 | ||||||||||||
Other assets | (7,807 | ) | (4,517 | ) | (10,348 | ) | 15,544 | |||||||||||
Deferred revenue and customer advances | (3,786 | ) | (27,537 | ) | (28,339 | ) | (62,901 | ) | ||||||||||
Accounts payable and accrued expenses | 16,739 | 51,393 | (9,279 | ) | 52,377 | |||||||||||||
Retirement plan contributions | (4,069 | ) | (18,017 | ) | (5,241 | ) | (24,677 | ) | ||||||||||
Accrued income taxes | 5,406 | 11,346 | 5,406 | 11,346 | ||||||||||||||
Net cash provided by continuing operations | 101,965 | 106,830 | 125,808 | 132,127 | ||||||||||||||
Net cash provided by (used for) discontinued operations | - | 1,062 | (4,225 | ) | 1,850 | |||||||||||||
Net cash provided by operating activities | 101,965 | 107,892 | 121,583 | 133,977 | ||||||||||||||
Cash flows from investing activities: | ||||||||||||||||||
Purchases of property, plant and equipment | (22,336 | ) | (18,119 | ) | (44,467 | ) | (35,706 | ) | ||||||||||
Purchases of available-for-sale marketable securities | (287,252 | ) | (128,421 | ) | (498,541 | ) | (223,820 | ) | ||||||||||
Proceeds from sales of available-for-sale marketable securities | 232,029 | 40,197 | 420,477 | 47,267 | ||||||||||||||
Proceeds from sales of trading marketable securities | - | 23,550 | - | 23,700 | ||||||||||||||
Proceeds from life insurance | - | 1,091 | - | 1,091 | ||||||||||||||
Net cash used for continuing operations | (77,559 | ) | (81,702 | ) | (122,531 | ) | (187,468 | ) | ||||||||||
Net cash provided by discontinued operations | 32 | - | 39,062 | - | ||||||||||||||
Net cash used by investing activities | (77,527 | ) | (81,702 | ) | (83,469 | ) | (187,468 | ) | ||||||||||
Cash flows from financing activities: | ||||||||||||||||||
Issuance of common stock | 6,976 | 35,794 | 17,052 | 41,873 | ||||||||||||||
Tax benefit related to stock options and restricted stock units | 3,717 | - | 3,717 | - | ||||||||||||||
Payments of long-term debt | - | - | (1,222 | ) | (1,123 | ) | ||||||||||||
Net cash provided by continuing operations | 10,693 | 35,794 | 19,547 | 40,750 | ||||||||||||||
Net cash provided by discontinued operations | - | - | - | - | ||||||||||||||
Net cash provided by financing activities | 10,693 | 35,794 | 19,547 | 40,750 | ||||||||||||||
Increase (decrease) in cash and cash equivalents | 35,131 | 61,984 | 57,661 | (12,741 | ) | |||||||||||||
Cash and cash equivalents at beginning of period | 420,267 | 342,012 | 397,737 | 416,737 | ||||||||||||||
Cash and cash equivalents at end of period | $ | 455,398 | $ | 403,996 | $ | 455,398 | $ | 403,996 | ||||||||||
GAAP to Non-GAAP Earnings Reconciliation | |||||||||||||||||||||||||||||||||||||||||||||||||
(In millions, except per share amounts) | |||||||||||||||||||||||||||||||||||||||||||||||||
Quarter Ended | |||||||||||||||||||||||||||||||||||||||||||||||||
July 3, 2011 |
% of Net |
April 3, 2011 |
% of Net |
|
July 4, 2010 |
% of Net |
|||||||||||||||||||||||||||||||||||||||||||
Net Revenues | $ | 410.5 | $ | 377.2 | $ | 445.3 | |||||||||||||||||||||||||||||||||||||||||||
Income from Operations - GAAP | $ | 101.6 | 24.8 | % | $ | 78.5 | 20.8 | % | $ | 136.1 | 30.6 | % | |||||||||||||||||||||||||||||||||||||
Acquired intangible |
7.3 | 1.8 | % | 7.3 | 1.9 | % | 7.3 | 1.6 | % | ||||||||||||||||||||||||||||||||||||||||
Restructuring and |
1.3 | 0.3 | % | 0.4 | 0.1 | % | 0.4 | 0.1 | % | ||||||||||||||||||||||||||||||||||||||||
Income from |
$ | 110.2 | 26.8 | % | $ | 86.2 | 22.9 | % | $ | 143.8 | 32.3 | % | |||||||||||||||||||||||||||||||||||||
Income |
Income |
|
Income |
||||||||||||||||||||||||||||||||||||||||||||||
July 3, 2011 |
% of Net |
Basic |
Diluted | April 3, 2011 |
% of Net |
Basic | Diluted | July 4, 2010 |
% of Net |
Basic | Diluted | ||||||||||||||||||||||||||||||||||||||
Income from Continuing Operations - GAAP | $ | 89.9 | 21.9 | % | $ | 0.48 | $ | 0.39 | $ | 68.1 | 18.1 | % | $ | 0.37 | $ | 0.29 | $ | 122.5 | 27.5 | % | $ | 0.68 | 0.55 | ||||||||||||||||||||||||||
Acquired intangible asset amortization | 7.3 | 1.8 | % | 0.04 | 0.04 | 7.3 | 1.9 | % | 0.04 | 0.03 | 7.3 | 1.6 | % | 0.04 | 0.04 | ||||||||||||||||||||||||||||||||||
Restructuring and other, net (1) | 1.3 | 0.3 | % | 0.01 | 0.01 | 0.4 | 0.1 | % | - | - | 0.4 | 0.1 | % | - | - | ||||||||||||||||||||||||||||||||||
Convertible share adjustment (2) | - | - | - | 0.05 | - | - | - | 0.06 | - | - | - | 0.09 | |||||||||||||||||||||||||||||||||||||
Interest and other (3) | 3.0 | 0.7 | % | 0.02 | 0.01 | 2.9 | 0.8 | % | 0.02 | 0.01 | 2.6 | 0.6 | % | 0.01 | 0.01 | ||||||||||||||||||||||||||||||||||
Income from Continuing Operations - non-GAAP | $ | 101.5 | 24.7 | % | $ | 0.55 | $ | 0.50 | $ | 78.7 | 20.9 | % | $ | 0.43 | $ | 0.39 | $ | 132.8 | 29.8 | % | $ | 0.74 | $ | 0.69 | |||||||||||||||||||||||||
GAAP and Non-GAAP Weighted Average Common Shares - Basic | 185.4 | 184.7 | 180.0 | ||||||||||||||||||||||||||||||||||||||||||||||
GAAP Weighted Average Common Shares - Diluted | 230.5 | 232.1 | 231.5 | ||||||||||||||||||||||||||||||||||||||||||||||
Exclude dilutive |
(22.7 | ) | (23.4 | ) | (34.7 | ) | |||||||||||||||||||||||||||||||||||||||||||
Non-GAAP Weighted Average Common Shares - Diluted (2) | 207.8 | 208.7 | 196.8 | ||||||||||||||||||||||||||||||||||||||||||||||
(1) Restructuring and other, net consists of (in millions): | |||||||||||||||||||||||||||||||||||||||||||||||||
Quarter Ended | |||||||||||||||||||||||||||||||||||||||||||||||||
July 3, 2011 | April 3, 2011 | July 4, 2010 | |||||||||||||||||||||||||||||||||||||||||||||||
Employee Severance | $ | 0.3 | $ | 0.8 | $ | 0.4 | |||||||||||||||||||||||||||||||||||||||||||
Non-U.S. Pension Settlement | 0.9 | - | - | ||||||||||||||||||||||||||||||||||||||||||||||
Facility Related | - | (0.4 | ) | - | |||||||||||||||||||||||||||||||||||||||||||||
$ | 1.3 | $ | 0.4 | $ | 0.4 | ||||||||||||||||||||||||||||||||||||||||||||
(2) For the quarters ended July 3, 2011, April 3, 2011 and July 4, 2010, the calculation of non-GAAP diluted earnings per share gives benefit to the Company's call option on its stock for 34.7 million shares at $5.48. As a result, 17.9 million, 18.8 million and 11.2 million shares, respectively, have been included in non-GAAP diluted shares and net interest expense of $2.4 million has been added back to non-GAAP net income for the non-GAAP diluted earnings per share calculation. | |||||||||||||||||||||||||||||||||||||||||||||||||
(3) For the quarters ended July 3, 2011, April 3, 2011 and July 4, 2010, Interest and Other included non-cash convertible debt interest. | |||||||||||||||||||||||||||||||||||||||||||||||||
Six Months Ended | ||||||||||||||||||||||||||||||||||||||
July 3, 2011 |
% of Net |
July 4, 2010 |
% of Net |
|||||||||||||||||||||||||||||||||||
Net Revenues | $ | 787.7 | $ | 764.6 | ||||||||||||||||||||||||||||||||||
Income from Operations - GAAP | $ | 180.1 | 22.9 | % | $ | 195.1 | 25.5 | % | ||||||||||||||||||||||||||||||
Acquired intangible asset amortization | 14.6 | 1.9 | % | 14.7 | 1.9 | % | ||||||||||||||||||||||||||||||||
Restructuring and other, net (1) | 1.7 | 0.2 | % | 1.3 | 0.2 | % | ||||||||||||||||||||||||||||||||
Income from Operations - non-GAAP | $ | 196.4 | 24.9 | % | $ | 211.1 | 27.6 | % | ||||||||||||||||||||||||||||||
|
Income |
Income |
||||||||||||||||||||||||||||||||||||
July 3, 2011 |
% of Net |
Basic | Diluted | July 4, 2010 |
% of Net |
Basic | Diluted | |||||||||||||||||||||||||||||||
Income from Continuing Operations - GAAP | $ | 158.0 | 20.1 | % | $ | 0.85 | $ | 0.68 | $ | 171.6 | 22.4 | % | $ | 0.97 | $ | 0.79 | ||||||||||||||||||||||
Acquired intangible asset amortization | 14.6 | 1.9 | % | $ | 0.08 | 0.07 | 14.7 | 1.9 | % | 0.08 | 0.08 | |||||||||||||||||||||||||||
Interest and other (2) | 5.8 | 0.7 | % | $ | 0.03 | 0.03 | 5.1 | 0.7 | % | 0.03 | 0.03 | |||||||||||||||||||||||||||
Restructuring and other, net (1) | 1.7 | 0.2 | % | $ | 0.01 | 0.01 | 1.3 | 0.2 | % | 0.01 | 0.01 | |||||||||||||||||||||||||||
Convertible share adjustment (3) | - | - | $ | - | 0.10 | - | - | - | 0.11 | |||||||||||||||||||||||||||||
Income from Continuing Operations - non-GAAP | $ | 180.1 | 22.9 | % | $ | 0.97 | $ | 0.89 | $ | 192.7 | 25.2 | % | $ | 1.08 | $ | 1.02 | ||||||||||||||||||||||
GAAP and Non-GAAP Weighted Average Common Shares - Basic | 185.0 | 178.4 | ||||||||||||||||||||||||||||||||||||
GAAP Weighted Average Common Shares - Diluted | 231.3 | 228.9 | ||||||||||||||||||||||||||||||||||||
Exclude dilutive shares from convertible note | (23.0 | ) | (34.7 | ) | ||||||||||||||||||||||||||||||||||
Non-GAAP Weighted Average Common Shares - Diluted (3) | 208.3 | 194.2 | ||||||||||||||||||||||||||||||||||||
(1) Restructuring and other, net consists of: | ||||||||||||||||||||||||||||||||||||||
Six Months Ended | ||||||||||||||||||||||||||||||||||||||
July 3, 2011 | July 4, 2010 | |||||||||||||||||||||||||||||||||||||
Employee Severance | $ | 1.2 | $ | 1.3 | ||||||||||||||||||||||||||||||||||
Non-U.S. Pension Settlement | 0.9 | - | ||||||||||||||||||||||||||||||||||||
Facility Related | (0.4 | ) | - | |||||||||||||||||||||||||||||||||||
$ | 1.7 | $ | 1.3 | |||||||||||||||||||||||||||||||||||
(2)For the six months ended July 3, 2011 and July 4, 2010, Interest and Other included non-cash convertible debt interest. | ||||||||||||||||||||||||||||||||||||||
(3)For the six months ended July 3, 2011 and July 4, 2010, the calculation of non-GAAP diluted earnings per share gives benefit to the Company's call option on its stock for 34.7 million shares at $5.48. As a result, 23.0 million and 10.2 million shares, respectively, have been included in non-GAAP diluted shares and net interest expense of approximately $4.8 million has been added back to non-GAAP net income for the non-GAAP diluted earnings per share calculation. | ||||||||||||||||||||||||||||||||||||||
GAAP to Non-GAAP Reconciliation of Third Quarter 2011 guidance: | ||||||||||||||||||||||||||||||||||||||
GAAP and Non-GAAP third quarter revenue guidance: | $320 million | to | $340 million | |||||||||||||||||||||||||||||||||||
GAAP income from continued operations per diluted share | $ | 0.15 | $ | 0.18 | ||||||||||||||||||||||||||||||||||
Exclude acquired intangible asset amortization | $ | 0.03 | $ | 0.03 | ||||||||||||||||||||||||||||||||||
Exclude non-cash convertible debt interest | $ | 0.01 | $ | 0.01 | ||||||||||||||||||||||||||||||||||
Exclude dilutive shares from convertible note | $ | 0.03 | $ | 0.04 | ||||||||||||||||||||||||||||||||||
Non-GAAP income from continuing operations per diluted share | $ | 0.22 | $ | 0.26 | ||||||||||||||||||||||||||||||||||